Press Releases

Press Releases

Pipeline of potential first-in-class therapies on track to deliver two pivotal readouts in 2021 SAN DIEGO , Jan. 11, 2021 (GLOBE NEWSWIRE) -- Travere Therapeutics (NASDAQ: TVTX) today announced that, based on preliminary and unaudited financial data, the Company expects net product sales for the
Jan 11, 2021